Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (14 trials)
adalimumab (humira) (3 trials)
alendronic acid (fosamax) (1 trial)
allogeneic cord blood (1 trial)
alteplase (Activase) (1 trial)
amlodipine (norvasc) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atorvastatin (lipitor) (7 trials)
attenuated hav vaccine, h2 strain (2 trials)
attenuated hav vaccine, l-a-1 strain (1 trial)
attenuated measles vaccine (rubeovax) (1 trial)
autologous mesenchymal stem cells (6 trials)
belimumab (benlysta) (2 trials)
betamethasone (celestone) (1 trial)
bictegravir (Biktarvy) (1 trial)
bifidobacterium animalis (3 trials)
bivalirudin (angiomax) (2 trials)
bortezomib (velcade) (12 trials)
calcitriol (rocaltrol) (1 trial)
canagliflozin (invokana) (1 trial)
capecitabine (xeloda) (49 trials)
caspofungin (cancidas) (1 trial)
cimicifuga foetida l. (1 trial)
cisplatin (platinol) (75 trials)
clopidogrel (plavix) (9 trials)
conjugated equine estrogens (1 trial)
cyclosporine (sandimmune) (10 trials)
cytarabine (cytosar-u) (14 trials)
dapagliflozin (farxiga) (2 trials)
dasatinib (sprycel) (4 trials)
desogestrel (Mercilon) (1 trial)
dexmedetomidine (precedex) (3 trials)
doxorubicin (Doxil) (18 trials)
dydrogesterone (gynorest) (2 trials)
efavirenz (sustiva) (5 trials)
eltrombopag (promacta) (5 trials)
empagliflozin (jardiance) (1 trial)
emtricitabine (emtriva) (1 trial)
enoxaparin (lovenox) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
etoposide (vepesid) (22 trials)
everolimus (zortress) (2 trials)
exemestane (aromasin) (5 trials)
filgrastim (neupogen) (14 trials)
glimepiride (amaryl) (1 trial)
human factor ix complex (prothrombin complex concentrate) (Kcentra) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
hydrocortisone (solu-cortef) (2 trials)
idarubicin (idamycin) (4 trials)
inactivated hav vaccine, lu8 strain (2 trials)
interferon alpha-2b (Intron-A) (5 trials)
irinotecan (Camptosar) (28 trials)
Lactobacillus acidophilus (4 trials)
lamivudine (epivir) (3 trials)
lenalidomide (revlimid) (7 trials)
levothyroxine (Synthroid) (3 trials)
live attenuated chimeric japanese encephalitis vaccine (1 trial)
metformin (glucophage) (5 trials)
methylprednisolone (medrol) (3 trials)
metoprolol (lopressor) (1 trial)
mirtazapine (remeron) (1 trial)
monovalent group a meningococcal vaccine (2 trials)
montelukast (singulair) (1 trial)
pegaspargase (oncaspar) (4 trials)
pemetrexed (alimta) (14 trials)
pioglitazone (actos) (1 trial)
pitavastatin (livalo) (2 trials)
poliovirus vaccine inactivated (5 trials)
pomalidomide (pomalyst) (2 trials)
prednisolone (hydeltra) (2 trials)
prednisone (meticorten) (26 trials)
qishen yiqi dripping (1 trial)
rituximab (rituxan) (29 trials)
rosuvastatin (crestor) (4 trials)
simvastatin (zocor) (3 trials)
sirolimus (rapamune) (10 trials)
sitagliptin (januvia) (2 trials)
sodium glycididazole (1 trial)
sulfisoxazole (gantrisin) (1 trial)
tacrolimus (prograf) (3 trials)
telmisartan (micardis) (1 trial)
tenecteplase (tnkase) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
thalidomide (Thalomid) (8 trials)
ticagrelor (brilinta) (5 trials)
tocilizumab (actemra) (4 trials)
tranexamic acid (cyklokapron) (10 trials)
trastuzumab (herceptin) (10 trials)
unfractionated heparin (1 trial)
ursodeoxycholic acid (2 trials)
vincristine (oncovin) (12 trials)
vinorelbine (navelbine) (12 trials)
acalabrutinib (calquence) (2 trials)
acetaminophen (tylenol) (1 trial)
adapalene (differin) (2 trials)
aflibercept (zaltrap) (1 trial)
antigen pulsed dendritic cells (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)
antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (3 trials)
attenuated mumps vaccine (2 trials)
autologous bone marrow derived mesenchymal cells (1 trial)
azacitidine (vidaza) (4 trials)
bendamustine (treanda) (2 trials)
bevacizumab (avastin) (14 trials)
bifidobacterium lactis (1 trial)
bivalent oral polio vaccine (bopv), type 1 and type 3 (2 trials)
carboplatin (paraplatin) (38 trials)
cetuximab (erbitux) (6 trials)
chlorambucil (Leukeran) (2 trials)
cilostazol (pletal) (2 trials)
dacarbazine (dtic-dome) (2 trials)
daunorubicin (cerubidine) (4 trials)
decitabine (dacogen) (6 trials)
dendrobium huoshanense (1 trial)
docetaxel (taxotere) (25 trials)
durvalumab (imfinzi) (6 trials)
endostatin (endostar) (14 trials)
epirubicin (ellence) (15 trials)
erlotinib (tarceva) (3 trials)
etanercept (enbrel) (2 trials)
fludarabine (fludara) (6 trials)
fluorouracil (efudex) (25 trials)
fulvestrant (faslodex) (7 trials)
gemcitabine (gemzar) (17 trials)
immune globulin (human) (1 trial)
inactivated influenza vaccine (3 trials)
inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)
inactivated SARS-Cov-2 vaccine (6 trials)
indomethacin (indocin) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
lactobacillus plantarum (1 trial)
live oral poliovirus type 1, 2 and 3 (1 trial)
lumefantrine (Coartem) (1 trial)
meningococcal a&c vaccine (1 trial)
mercaptopurine (purinethol) (3 trials)
oprelvekin (Neumega) (2 trials)
osimertinib (tagrisso) (3 trials)
oxaliplatin (eloxatin) (45 trials)
paclitaxel (taxol) (98 trials)
pembrolizumab (keytruda) (7 trials)
abiraterone (zytiga) (1 trial)
acetylcysteine (mucomyst) (1 trial)
afatinib (gilotrif) (2 trials)
aldesleukin (proleukin) (2 trials)
alectinib (alecensa) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic central memory t cells (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
anastrozole (arimidex) (2 trials)
arsenic trioxide (trisenox) (2 trials)
asparaginase (elspar) (1 trial)
astragalus membranaceus (1 trial)
atezolizumab (tecentriq) (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
autologous adipose tissue (1 trial)
autologous gp96 vaccination (1 trial)
autologous hematopoietic cell (1 trial)
autologous lymphocytes (1 trial)
autologous mesenchymal stem cell-derived neural progenitors (2 trials)
autologous T cell memory cells (1 trial)
avapritinib (Ayvakit) (1 trial)
baricitinib (olumiant) (2 trials)
bicalutamide (casodex) (1 trial)
black cohosh extract (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
celecoxib (celebrex) (1 trial)
dacomitinib (vizimpro) (1 trial)
daratumumab (darzalex) (1 trial)
dendritic cell activated cytokine-induced killer cell (1 trial)
encorafenib (braftovi) (1 trial)
esophageal cancer peptide specific ctl (1 trial)
etirinotecan pegol (Onzeald) (2 trials)
ferric carboxymaltose (Injectafer) (1 trial)
goserelin (zoladex) (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
ibrutinib (imbruvica) (3 trials)
itraconazole (sporanox) (1 trial)
lenvatinib (lenvima) (10 trials)
levamisole (ergamisol) (4 trials)
levoleucovorin (fusilev) (1 trial)
live attenuated mumps vaccine (2 trials)
loratadine (claritin) (1 trial)
measles and mumps vaccine (1 trial)
melphalan (alkeran) (3 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (4 trials)
monosialoganglioside (1 trial)
neratinib maleate (nerlynx) (1 trial)
olaparib (lynparza) (2 trials)
palbociclib (ibrance) (4 trials)
periplaneta americana (1 trial)
prochlorperazine (compazine) (1 trial)
regorafenib (stivarga) (2 trials)
romiplostim (nplate) (1 trial)
sacituzumab govitecan (1 trial)
sodium iodide i-131 (iodotope) (1 trial)
thymalfasin (zadaxin) (2 trials)
topotecan (hycamtin) (1 trial)
tripterygium wilfordii (1 trial)
umbilical cord mesenchymal stem cells (14 trials)
vemurafenib (zelboraf) (1 trial)
68ga-1,4,7-triazacyclononane-n,n',n''-triacetic acid (1 trial)
68ga-bbn-irdye800cw (2 trials)
[68ga]ga-hbed-cc-exendin-4 (1 trial)
allogeneic gamma-delta t cells (2 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (2 trials)
car-cldn18.2 t-cells (1 trial)
cd19/cd20 bispecific car-t cells (1 trial)
choline c11 (choline c-11) (2 trials)
Embryonic Stem Cells (1 trial)
enfuvirtide (fuzeon) (1 trial)
fludeoxyglucose f-18 (2 trials)
gallium-68-dotatate (netspot) (2 trials)
human embryonic stem cell derived retinal pigmented epithelial cells (1 trial)
inactivated rotavirus vaccine (1 trial)
indocyanine green (ic-green) (3 trials)
live attenuated mumps (f-genotype) vaccine (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
mianhuahua flavonoids (1 trial)
anti-gpc3-irdye800cw (1 trial)
autologous umbilical cord blood (1 trial)
azathioprine (imuran) (1 trial)
bromocriptine (parlodel) (2 trials)
cabergoline (dostinex) (3 trials)
cefoperazone (cefobid) (1 trial)
doxycycline (vibramycin) (1 trial)
entecavir (baraclude) (1 trial)
escitalopram (lexapro) (1 trial)
felodipine (plendil) (1 trial)
frovatriptan (frova) (1 trial)
glipizide (glucotrol) (1 trial)
hiv-1 specific car-t cells (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
leflunomide (arava) (3 trials)
loperamide (imodium) (1 trial)
methylene blue (proveblue) (2 trials)
naratriptan (amerge) (1 trial)
neostigmine (bloxiverz) (1 trial)
nesiritide (natrecor) (1 trial)
octreotide (sandostatin) (1 trial)
onabotulinumtoxinA (Botox) (1 trial)
oxytocin (syntocinon) (1 trial)
Acne Vulgaris (Phase 3)
Acquired Hyperostosis Syndrome (Phase 1)
Acquired Immunodeficiency Syndrome (Phase 1)
Acute Coronary Syndrome (Phase 4)
Acute Disease (Phase 2)
Acute Lung Injury (Phase 2)
Adenocarcinoma (Phase 4)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 3)
Adenoma (Phase 3)
Adenoma, Islet Cell (Phase 2)
Adenoviridae Infections (Phase 1)
Airway Remodeling (Phase 4)
Amyloidosis (Phase 2)
Anemia (Phase 4)
Anemia, Aplastic (Phase 4)
Anemia, Hemolytic (Phase 4)
Anemia, Hemolytic, Autoimmune (Phase 4)
Anemia, Iron-Deficiency (Phase 2)
Anus Neoplasms (Phase 2)
Aortic Arch Syndromes (Phase 3)
Aortic Valve Stenosis (Phase 4)
Arteritis (Phase 3)
Arthritis (Phase 3)
Arthritis, Juvenile (Phase 1)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 4)
Astrocytoma (Phase 3)
Atherosclerosis (Phase 3)
Atrial Fibrillation (Phase 4)
Autoimmune Diseases (Phase 2)
Behcet Syndrome (Phase 3)
Biliary Tract Neoplasms (Phase 2)
Bradycardia (Phase 4)
Brain Injuries (Phase 1)
Brain Neoplasms (Phase 3)
Brain Stem Neoplasms (Phase 2)
Breast Diseases (Phase 3)
Breast Neoplasms (Phase 4)
Bronchiectasis (Phase 3)
Bronchitis (Phase 2)
Carcinoma (Phase 4)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Ductal (Phase 1)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma in Situ (Phase 3)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Pancreatic Ductal (Phase 1)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 4)
Carcinoma, Transitional Cell (Phase 2)
Cardiac Complexes, Premature (Phase 4)
Cardiomyopathies (Phase 4)
Cardiomyopathy, Dilated (Phase 4)
Carotid Stenosis (Phase 4)
Castleman Disease (Phase 2)
Cerebral Infarction (Phase 3)
Cerebrovascular Disorders (Phase 3)
Cervical Intraepithelial Neoplasia (Phase 3)
Chemotherapy-Induced Febrile Neutropenia (Phase 3)
Cholangiocarcinoma (Phase 3)
Cholangitis (Phase 4)
Chordoma (Phase 2)
Choroidal Neovascularization (Phase 1)
Cognitive Dysfunction (Phase 2)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 4)
Congenital Abnormalities (Phase 4)
Connective Tissue Diseases (Phase 4)
Constriction, Pathologic (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Cryopyrin-Associated Periodic Syndromes (Phase 2)
Cystadenocarcinoma (Phase 2)
Deficiency Diseases (Phase 2)
Delirium (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 4)
Digestive System Diseases (Phase 2)
Digestive System Neoplasms (Phase 2)
Disease (Phase 4)
Dysbiosis (Phase 3)
Dysmenorrhea (Phase 4)
Eczema (Phase 4)
Edema (Phase 3)
Edema, Cardiac (Phase 3)
Encephalitis (Phase 3)
Encephalitis, Japanese (Phase 3)
Endometrial Hyperplasia (Phase 3)
Endometriosis (Phase 4)
Enterovirus Infections (Phase 4)
Epilepsy (Phase 2)
Erectile Dysfunction (Phase 2)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 4)
Esophageal Squamous Cell Carcinoma (Phase 3)
Essential Hypertension (Phase 4)
Fallopian Tube Neoplasms (Phase 3)
Familial Hypophosphatemic Rickets (Phase 4)
Familial Primary Pulmonary Hypertension (Phase 2)
Fatigue (Phase 2)
Febrile Neutropenia (Phase 4)
Fever (Phase 4)
Fibrosis (Phase 2)
Fistula (Phase 4)
Foot-and-Mouth Disease (Phase 4)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 4)
Gastrointestinal Stromal Tumors (Phase 2)
Gestational Trophoblastic Disease (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Graft vs Host Disease (Phase 3)
Granulomatous Mastitis (Phase 4)
Hand, Foot and Mouth Disease (Phase 4)
Head and Neck Neoplasms (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 4)
Heart Failure, Systolic (Phase 3)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 4)
Hemoglobinuria (Phase 4)
Hemoglobinuria, Paroxysmal (Phase 4)
Hemolysis (Phase 2)
Hemophilia A (Phase 3)
Hemorrhage (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV Infections (Phase 4)
Hypercholesterolemia (Phase 3)
Hyperlipoproteinemia Type II (Phase 2)
Hyperplasia (Phase 3)
Hypersensitivity (Phase 4)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 2)
Hypertriglyceridemia (Phase 4)
Hypertrophy (Phase 3)
Hypopharyngeal Neoplasms (Phase 2)
Hypophosphatemia (Phase 4)
Hypothyroidism (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 2)
Immune System Diseases (Phase 2)
Immunoglobulin G4-Related Disease (Phase 4)
Immunologic Deficiency Syndromes (Phase 1)
Infarction (Phase 4)
Infections (Phase 4)
Infertility (Phase 2)
Infertility, Female (Phase 2)
Inflammation (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Influenza, Human (Phase 3)
Insulin Resistance (Phase 4)
Intestinal Diseases (Phase 1)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Ischemia (Phase 3)
Kidney Diseases (Phase 4)
Leiomyoma (Phase 4)
Leiomyomatosis (Phase 4)
Leukemia (Phase 4)
Leukemia, Large Granular Lymphocytic (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Biliary (Phase 4)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 4)
Lung Injury (Phase 2)
Lung Neoplasms (Phase 4)
Lupus Erythematosus, Systemic (Phase 3)
Lymphatic Diseases (Phase 1)
Lymphatic Metastasis (Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 3)
Macular Degeneration (Phase 3)
Macular Edema (Phase 3)
Malaria, Falciparum (Phase 3)
Malnutrition (Phase 3)
Mastitis (Phase 4)
Melanoma (Phase 3)
Meningitis (Phase 3)
Meningitis, Meningococcal (Phase 3)
Menopause, Premature (Phase 2)
Mouth Diseases (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 4)
Mumps (Phase 3)
Muscular Dystrophies (Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Myelodysplastic Syndromes (Phase 1)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 4)
Myofibroma (Phase 4)
Myopia (Phase 1)
Nasal Septal Perforation (Phase 2)
Nasopharyngeal Carcinoma (Phase 4)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 4)
Neoplasms by Site (Phase 3)
Neoplasms, Connective Tissue (Phase 1)
Neoplasms, Plasma Cell (Phase 4)
Neoplasms, Second Primary (Phase 3)
Neoplasms, Squamous Cell (Phase 2)
Neovascularization, Pathologic (Phase 1)
Neuroendocrine Tumors (Phase 2)
Neurotoxicity Syndromes (Phase 2)
Neutropenia (Phase 4)
Nevus, Blue (Phase 4)
Osteoarthropathy, Primary Hypertrophic (Phase 3)
Osteoarthropathy, Secondary Hypertrophic (Phase 3)
Osteomalacia (Phase 1)
Osteoporosis (Phase 3)
Osteoporosis, Postmenopausal (Phase 3)
Ovarian Neoplasms (Phase 3)
Overweight (Phase 4)
Pancreatic Fistula (Phase 4)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 4)
Pancytopenia (Phase 2)
Papillomavirus Infections (Phase 4)
Parkinson Disease (Phase 2)
Parotitis (Phase 3)
